Stay updated with breaking news from Paxmedica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher PaxMedica shares tumbled to an all-time low on Monday after the biopharmaceutical company said it was raising $7 million in a dilutive. ....
PaxMedica, Inc. (PXMD) shares are spiking more than 141 percent on Tuesday morning trade after the biopharmaceutial company announced the publication of statistically significant improvements in its Autism spectrum disorder phase 2 study results. ....
By Chris Wack PaxMedica shares tripled to $8.52 after the company saw positive results from research exploring the potential of low-dose suramin for autism. ....
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) via IBN PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to. ....